Headquartered in Silicon Valley, Saama is the leading data science services and solutions company delivering Analytics Advantage to Global 2000 clients.

Our Fluid Analytics EngineTM maximizes existing customer infrastructure, allowing us to focus on the white space between existing capabilities and the critical business questions that need to be answered. We are unique in our ability to combine our Fluid Analytics Engine with our vertical expertise to drive the rapid adoption of advanced analytics into company-specific business processes in a matter of weeks. We give our clients Analytics Advantage by strategically using internal and external data assets to grow revenue, improve operating efficiencies and delight customers in new ways. Clients include Actelion, Brocade, Broadcom, Cisco, CSAA Insurance, Delta Dental, Dignity Health, PayPal, Salesforce.com and Unilever.

For additional information, please visit www.saama.com.

Saama in the News
Campbell, CA (May 15, 2018) – Saama Technologies, a leading clinical and health data analytics company, and ICON plc(NASDAQ: ICLR), a global provider of drug development and commercialization solutions and services, have partnered to accelerate the use of Real World Evidence (RWE) across the product lifecycle and drive mission critical decisions for medical affairs, reimbursement and commercialization functions.
May 15, 2018
CAMPBELL, CA (April 02, 2018)— Saama Technologies, Inc., a leading clinical data analytics company, today announced that Kenneth L. Massey, Pharm.D., one of the foremost medical affairs professionals in the life sciences industry, has joined the company in the key position of Chief Life Sciences Officer. Ken brings 30 years of medical affairs and drug development experience at leading global pharmaceutical companies to his new role at Saama.
By Stephen Strigle
April 2, 2018
AUSTIN, TX & CAMPBELL, CA (February 28, 2018) – Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, is partnering with Saama Technologies, Inc., a leading clinical data analytics company, to improve awareness of, access to, and participation in clinical trials for U.S. physicians and patients.
By Stephen Strigle
March 1, 2018
London (February 12, 2018) – Today, Citeline, part of Informa Pharma Intelligence’s suite of pharmaceutical, medtech and biomedical research and analysis solutions, and Saama Technologies, Inc., a leading clinical analytics company, announced a partnership to integrate Citeline’s application programming interfaces (APIs) with Saama’s artificial intelligence and deep learning solutions.
By Stephen Strigle
February 13, 2018
Santa Clara, CA (February 12, 2018) – Based on its recent analysis of the real-world evidence (RWE) IT solutions market, Frost & Sullivan recognizes Saama Technologies (Saama) with the 2018 Global Enabling Technology Leadership Award for its fluid analytics platform, a set of cloud-enabled Big Data management and analytics solutions that support clients’ needs to simultaneously organize, process and translate unstructured, semi-structured, and structured data, especially in the pharmaceutical and biotechnology clinical trial and drug discovery segments.
By Stephen Strigle
February 12, 2018
Campbell, CA (February 4, 2018) – Saama Technologies, Inc., a leading clinical analytics company, has received not one, but two awards at the Big Data & Analytics Converge 2018. The company received the “Innovative Technology of the Year” award as well as the “Excellence in Industry Application” award in the B2B Sector.
By Stephen Strigle
February 6, 2018
About Carrick Capital Partners
Who We Are
A firm of enterprise software and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.